Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Minimum Inhibitory Concentration Determination of Equine Corynebacterium pseudotuberculosis Isolates From 1996 to 2012
D.M. Rhodes, K.G. Magdesian, B...
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
Read
Equine Corynebacterium pseudotuberculosis has not developed appreciable changes to minimum inhibitory concentrations (MIC) patterns over time. Authors’ addresses: William R. Pritchard Veterinary Medical Teaching Hospital, (Rhodes); Department of Medicine and Epidemiology, (Magdesian, Spier, Edman); Department of Clinical Pathology, Microbiology and Immunology, (Byrne); and Department of Population Health and Reproduction (Kass), School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis, CA 95616; e-mail: sjspier@ucdavis.edu.
1. Introduction
Few reports exist regarding the antimicrobial susceptibility patterns of C. pseudotuberculosis. The purpose of this study was to evaluate for temporal trends in the in vitro antimicrobial activities of 23 antimicrobials against equine C. pseudotuberculosis isolates. A secondary aim was to determine if a relationship exists between MIC and abscess location.
2. Materials and Methods
The study was retrospective and cross-sectional. Medical records were reviewed to obtain clinical and MIC data. Two hundred and seven C. pseudotuberculosis isolates from 196 horses were included. Minimum inhibitory concentrations were determined by the microdilution technique for isolates with missing MIC data. MIC values over three periods were compared (1996–2001, 2002–2006, 2007–2012).
3. Results
There were 140 horses with external abscesses, 20 with internal abscesses, 23 horses with both external and internal abscesses, and 4 with ulcerative lymphangitis. Commonly used antimicrobials with MIC50 and MIC90 values below the susceptibility break points used in this study included the amino-glycosides, doxycycline, erythromycin, azithromycin, chloramphenicol, enrofloxacin, rifampin, tetracycline, and trimethoprim-sulfamethoxazole. Ceftiofur, clarithromycin, ampicillin, and penicillin have variable break points depending on the micro-organism used, complicating interpretation. There were no significant changes in MIC values over the study period, and there was no relationship between MIC patterns and abscess location.
4. Discussion
C. pseudotuberculosis shows susceptibility to many antimicrobials and has not developed resistance over time; however, it is important to consider pharmacokinetics and pharmacodynamic properties of antimicrobials when formulating a treatment plan.
Acknowledgments
The authors would like to thank and recognize Dr. Eline Britz for providing the patient clinical data and Dr. Russ Sakai for data entry. This research was supported by the Center of Equine Health, University of California, Davis.
Conflict of Interest
The Authors declare no conflicts of interest.
Get access to all handy features included in the IVIS website
- Get unlimited access to books, proceedings and journals.
- Get access to a global catalogue of meetings, on-site and online courses, webinars and educational videos.
- Bookmark your favorite articles in My Library for future reading.
- Save future meetings and courses in My Calendar and My e-Learning.
- Ask authors questions and read what others have to say.
About
Affiliation of the authors at the time of publication
William R. Pritchard Veterinary Medical Teaching Hospital, (Rhodes); Department of Medicine and Epidemiology, (Magdesian, Spier, Edman); Department of Clinical Pathology, Microbiology and Immunology, (Byrne); and Department of Population Health and Reproduction (Kass), School of Veterinary Medicine, University of California, Davis, One Shields Ave., Davis, CA 95616
Comments (0)
Ask the author
0 comments